RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
RENOVORX, INC. (RNXT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 130.32 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 124.07K shares, a 1672.49% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 6.25K shares, a 36.93% decline year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 41.28K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 59.11K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 117.30K shares, a 64.92% decline from fiscal 2024.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 334.37K shares, a 322.37% increase from fiscal 2023.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 79.17K shares, a 13.81% decline from fiscal 2022.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 91.85K shares, a 258.45% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 124.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 130.32K shares 10-Q · filed 2026-08-13 | 171.60K shares derived: sum of 3 quarters · filed 2026-08-13 | 230.71K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 6.25K shares 10-Q · filed 2026-05-14 | 47.53K shares derived: sum of 2 quarters · filed 2026-05-14 | 106.64K shares derived: sum of 3 quarters · filed 2026-05-14 | 113.64K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 41.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 100.39K shares derived: sum of 2 quarters · filed 2026-03-30 | 107.39K shares derived: sum of 3 quarters · filed 2026-03-30 | 117.30K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 59.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 66.11K shares derived: sum of 2 quarters · filed 2025-11-13 | 76.02K shares 10-Q · filed 2025-11-13 | 76.02K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 7.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 16.91K shares 10-Q · filed 2025-08-14 | 16.91K shares derived: sum of 3 quarters · filed 2025-08-14 | 16.91K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 9.91K shares 10-Q · filed 2025-05-15 | 9.91K shares derived: sum of 2 quarters · filed 2025-05-15 | 9.91K shares derived: sum of 3 quarters · filed 2025-05-15 | 9.91K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-01 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-01 | 334.37K shares 10-K · filed 2025-04-01 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-13 | 334.37K shares 10-Q · filed 2024-11-13 | 362.28K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 334.37K shares 10-Q · filed 2024-08-13 | 362.28K shares derived: sum of 3 quarters · filed 2024-08-13 | 374.54K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 334.37K shares 10-Q · filed 2024-05-10 | 362.28K shares derived: sum of 2 quarters · filed 2024-05-10 | 374.54K shares derived: sum of 3 quarters · filed 2024-05-10 | 388.54K shares derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | 27.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 40.17K shares derived: sum of 2 quarters · filed 2024-04-01 | 54.17K shares derived: sum of 3 quarters · filed 2024-04-01 | 79.17K shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 12.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 26.25K shares derived: sum of 2 quarters · filed 2023-11-13 | 51.26K shares 10-Q · filed 2023-11-13 | 56.78K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 14.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | 39.00K shares 10-Q · filed 2023-08-16 | 44.52K shares derived: sum of 3 quarters · filed 2023-08-16 | 94.67K shares derived: sum of 4 quarters · filed 2023-08-16 |
| 2023-03-31 | 25.00K shares 10-Q · filed 2023-05-12 | 30.52K shares derived: sum of 2 quarters · filed 2023-05-12 | 80.67K shares derived: sum of 3 quarters · filed 2023-05-12 | 116.23K shares derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | 5.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 55.67K shares derived: sum of 2 quarters · filed 2023-03-31 | 91.23K shares derived: sum of 3 quarters · filed 2023-03-31 | 91.85K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 50.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 85.70K shares derived: sum of 2 quarters · filed 2022-11-14 | 86.33K shares 10-Q · filed 2022-11-14 | 88.33K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 35.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 36.19K shares 10-Q · filed 2022-08-12 | 38.19K shares derived: sum of 3 quarters · filed 2022-08-12 | |
| 2022-03-31 | 626.00 shares 10-Q · filed 2022-05-13 | 2.63K shares derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2021-12-31 | 2.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 25.63K shares 10-K · filed 2022-03-30 | ||
| 2021-09-30 | 23.63K shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |